When depression has not improved enough with traditional antidepressants, Spravato® may be an option to discuss with an experienced psychiatric provider. At The Schulte Institute in Scottsdale, Dr. Henry J. Schulte and our psychiatric care team provide Spravato® evaluation, insurance support, and supervised in-office treatment in a safe, structured clinical setting.
Find out whether Spravato® may be appropriate for your treatment history.
Spravato® is a prescription nasal spray for adults with treatment-resistant depression. It may be considered when a person has had an inadequate response to multiple antidepressant treatments.
During your consultation, our team will review your diagnosis, medication history, medical background, current symptoms, and treatment goals to determine whether Spravato® is clinically appropriate.
Spravato® may be worth discussing if you:
Traditional antidepressants often work through serotonin, norepinephrine, or dopamine pathways. Spravato® works differently and is administered as a nasal spray under medical supervision.
Because Spravato® can cause temporary side effects such as sedation, dissociation, dizziness, nausea, increased blood pressure, or impaired alertness, each treatment takes place in a certified healthcare setting with monitoring before you leave.
Spravato® is not taken at home. Patients are monitored after each session and need someone to drive them home. Patients should not drive, operate machinery, or do anything that requires full alertness until the next day after restful sleep.
Your first step is a consultation with our psychiatric team. We review your treatment history, symptoms, medications, medical history, and whether Spravato® is a safe and appropriate option.
Our administrative team helps verify benefits and prior authorization requirements. Coverage varies by plan, and approval is not guaranteed.
Spravato® is self-administered as a nasal spray under medical supervision in our Scottsdale office.
After treatment, you remain in the office for monitoring. Blood pressure, alertness, and overall response are assessed before discharge.
Your provider monitors progress and adjusts your treatment plan based on response, tolerability, and clinical need.
Treatment frequency depends on your diagnosis, response, and your provider’s clinical judgment. A common schedule for treatment-resistant depression includes:
Your provider will explain the recommended treatment plan during your evaluation.
The Schulte Institute provides advanced psychiatric treatment for patients who have not found adequate relief with traditional approaches. Our Scottsdale team offers comprehensive psychiatric evaluation, medication management, psychotherapy, TMS therapy, and Spravato® treatment.
The Schulte Institute accepts many commercial insurance plans for Spravato® treatment, including Aetna, BlueCross BlueShield, Cigna, Tricare, and UnitedHealthcare / Optum. Coverage is subject to plan benefits and prior authorization.
Spravato® is the brand name for esketamine nasal spray, a prescription treatment option for adults with treatment-resistant depression. It is administered under medical supervision in a certified healthcare setting.
Spravato® contains esketamine, which is related to ketamine but is an FDA-approved prescription nasal spray with specific dosing, monitoring, and REMS program requirements.
No. Spravato® is not dispensed for home use. Treatment must take place in a certified healthcare setting with appropriate monitoring.
Patients are monitored after each treatment session, so appointments generally require at least two hours in the office.
No. You will need someone to drive you home after each session. You should not drive or operate machinery until the next day after restful sleep.
Coverage depends on your insurance plan and prior authorization. The Schulte Institute helps verify benefits before treatment begins.
Spravato® treatment at The Schulte Institute is scheduled outpatient care. If you are in immediate danger, thinking about harming yourself, or experiencing a crisis, call or text 988 or go to the nearest emergency room.
If previous depression treatments have not helped enough, our Scottsdale psychiatric team can review your history and discuss whether Spravato® may be an appropriate next step.
